Search results for "Orchiectomy"

showing 4 items of 14 documents

Role of the vomeronasal system in intersexual attraction in female mice

2008

Although it is generally accepted that rodents' sociosexual behavior relies mainly on chemosignals, the specific roles played by the vomeronasal and olfactory systems in detecting these signals are presently unclear. This work reports the results of three experiments aimed at clarifying the role of the vomeronasal system on gender recognition and intersexual attraction, by analyzing the effects of lesions of the accessory olfactory bulbs (AOB) in chemically naive female mice. The first experiment demonstrates that lesions of the AOB abolish the preference that females show for male-soiled bedding in tests in which the females can contact the bedding, thus having access to both volatile and …

Olfactory systemMaleVomeronasal organZoologyolfactory systemUrinePheromonesOlfactory mucosaMiceSexual Behavior Animalsexual behaviorOlfactory MucosaConditioning PsychologicalmedicineAnimalsHabituationHabituation PsychophysiologicrewardCommunicationSex Characteristicsbusiness.industryGeneral Neuroscienceemotional learningAttractionOlfactory BulbOlfactory bulbSmellmedicine.anatomical_structureSex pheromoneData Interpretation StatisticalExploratory BehaviorPheromoneFemaleVomeronasal OrganbusinessPsychologypheromonesOrchiectomy
researchProduct

Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors.

2020

Abstract Introduction Chemotherapy for testicular germ cell tumors (GCT) is highly effective, with few patients who do not respond. Clinical studies to evaluated novel treatments are challenging given the rarity of these patients. Therefore, we sought to evaluate PD-L1 staining on metastatic and postchemotherapy viable testicular GCTs as a surrogate for potential benefit for immunotherapy targeting the PD-1/PD-L1 axis. Methods Ethics research committee approval for this retrospective study was obtained by four participating institutions (CHU de Quebec, St. Joseph's Health Care, Halifax Health Science Centre, Johannes Gutenberg University). Patients with viable metastatic testicular GCTs pat…

OncologyAdultMalemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyB7-H1 Antigen03 medical and health sciencesYoung Adult0302 clinical medicineTesticular NeoplasmsInternal medicinemedicineHumansOrchiectomyRetrospective StudiesChemotherapybusiness.industryChoriocarcinomaRetrospective cohort studySeminomaImmunotherapyNeoplasms Germ Cell and Embryonalmedicine.diseaseOncology030220 oncology & carcinogenesisImmunohistochemistryTeratomabusinessUrologic oncology
researchProduct

Evaluation of anti-androgenic activity of di-(2-ethylhexyl)phthalate

2005

International audience; DEHP is a widely used platiciser in the manufacture of PVC-based materials. It is known to disrupt the reproductive tract development in male rats. We have performed the Hershberger assay with DEHP on an immature castrated rat model to check if DEHP antagonise the testosterone propionate androgenic effect on the accessory sex organs development. DEHP significantly decreased the BC/LA muscles, the prostate, and the seminal vesicles relative weights from 100, 200, and 400 mg/kg bw/day, respectively. DEHP increased the liver relative weight from 100 mg/kg bw/day. A study was also performed on MDA-MB453 cell line stably transfected with pMMTVneo-Luc with DEHP and its maj…

Testosterone propionateMalemedicine.medical_specialtyendocrine systemMDA-MB453 TRANSFECTED CELL LINEmedicine.drug_classMetabolitePhthalic AcidsMONO-(2-ETHYLHEXYL1)PHTHALATE010501 environmental sciencesGenitalia MaleToxicologyAntiandrogen01 natural sciences03 medical and health scienceschemistry.chemical_compoundProstatePlasticizersInternal medicineCell Line TumorDiethylhexyl PhthalatemedicineAnimalsRats WistarLuciferases030304 developmental biology0105 earth and related environmental sciences0303 health sciencesDose-Response Relationship DrugPhthalateMONO-(2-ETHYL-5-HYDROXYLHEXYL)PHTHALATEBiological activityAndrogen AntagonistsDihydrotestosteroneDrug SynergismOrgan SizeMETABOLITES MONO-(2-ETHYL-5-OXOHEXYL1)PHTHALATEIn vitroRatsTestosterone PropionateEndocrinologymedicine.anatomical_structurechemistryLiverCell culture[SDV.TOX]Life Sciences [q-bio]/ToxicologyHERSHBERGER ASSAYDI-(2-ETHYLHEXYL1)PHTHALATEOrchiectomy
researchProduct

Gonadotropin-releasing hormone analogues for palliation of carcinoma of the prostate

1983

Since the introduction of contrasexual treatment as the basic concept of palliation of prostatic carcinoma in the 1940's, orchiectomy, estrogens, and, in recent years, antiandrogens have become generally accepted treatment forms. Three facts: 1) estrogen treatment being at best palliative and at worst dangerous; 2) surgical castration having psychological impacts, at least in the younger age group; and 3) both being probably ineffective from the beginning, have led us to investigate an alternative of minimal toxicity and possible reversibility in the initial treatment of advanced prostatic carcinoma. 12 patients with far advanced carcinoma of the prostate were treated with the gonadotropin …

medicine.medical_specialtybusiness.industrymedicine.drug_classUrologymedicine.medical_treatmentUrologyGonadotropin-releasing hormonemedicine.diseaseBuserelinSurgerymedicine.anatomical_structureProstateEstrogenmedicineCarcinomaOrchiectomybusinessTestosteroneGonadotropin-releasing hormone analoguemedicine.drugWorld Journal of Urology
researchProduct